Condition

Metastatic Lung Carcinoma

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 11 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials11
Recruiting3
Common interventions25
Lead sponsors shown7
Advertisement

Clinical trials

11 shown
Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung CancerNCT06743308 · 2024-12-16
RECRUITING
Tumor Treating Fields for the Treatment of Leptomeningeal Metastases of the Spine in Patients With Breast or Lung CancerNCT05746325 · 2023-04-07
RECRUITING
Evaluation of Anti-PD-1 Therapy by Monitoring T Cell Responses in Melanoma, Lung and Other Cancer TypesNCT06075524 · 2015-06-15
RECRUITING
Yittrium-90(Y-90) Fibroblast Activation Protein Inhibitor (FAPI) Therapy in Patients With Non-Small Cell Lung Cancer (Phase II)NCT07500285 · 2026-04-10
NOT_YET_RECRUITING
An Interactive Time-Restricted Diet Intervention (txt4fasting) for Reducing Neurocognitive Decline and Improving Survival in Patients With Brain Metastases From Breast or Lung CancerNCT06315296 · 2023-12-13
TERMINATED
A Video Intervention to Improve Patient Understanding of Tumor Genomic Testing in Patients With Metastatic CancerNCT05215769 · 2022-03-30
ACTIVE_NOT_RECRUITING
A Biobehavioral/Cognitive Treatment for Stress, Depression, and Anxiety in Patients With Stage IV Lung CancerNCT05342571 · 2021-06-01
COMPLETED
Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid MalignanciesNCT04785287 · 2021-03-29
TERMINATED
18F-FMAU PET/CT and MRI for the Detection of Brain Tumors in Patients With Brain Cancer or Brain MetastasesNCT04752267 · 2021-02-15
COMPLETED
Geriatric and Quality of Life Assessments in Older Patients With Non-metastatic or Metastatic Head and Neck or Lung Cancer Undergoing Surgery or Chemoradiation and Their CaregiversNCT03902535 · 2019-03-08
COMPLETED
Bronchoscopic Laser Ablation of Peripheral Lung TumorsNCT03707925 · 2018-09-18
TERMINATED

Common interventions

Trial status mix

COMPLETED3
RECRUITING3
TERMINATED3
ACTIVE_NOT_RECRUITING1
NOT_YET_RECRUITING1

Phase mix

NA6
PHASE22
EARLY_PHASE11
PHASE11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.